Nifty 50 opened at 25,255.50, down by 99.80 points (-0.39%) from its previous close of 25,355.25. Bank Nifty began the session at 56,843.45, declining 112.55 points (-0.20%) from its prior close of 56,956. Sensex started at 82,820.76, falling 369.52 points (-0.44%) compared to the previous close of 83,190.28. Gift Nifty opened at 25,295.50.
Global index as of 11 July 2025 (IST):
- DOW 30 rose by 192.34 points, closing at 44,650.60 (+0.43%).
- S&P 500 gained 17.20 points to settle at 6,280.46 (+0.27%).
- NASDAQ advanced by 19.33 points, ending at 20,630.70 (+0.09%).
- FTSE 100 surged 108.64 points to close at 8,975.66 (+1.23%).
- DAX declined by 92.75 points, closing at 24,456.80 (−0.38%).
- NIKKEI 225 dropped 174.92 points to finish at 39,646.40 (−0.44%).
Commodities Update:
- Gold: Currently trading at ₹9,841 per gram.
- Silver: Down by ₹0.10, now at ₹109.90 per gram.
- Crude Oil: Prices have risen by 0.06%, reaching 68.225, compared to the previous close of 68.185.
Global events/updates
Trump 2.0: Key Foreign Policy Updates
- Former U.S. President Donald Trump has announced a 35% tariff on Canadian imports, signaling a tougher trade stance. However, tariff exemptions under the USMCA agreement will reportedly remain intact, according to a U.S. official.
- Trump also hinted at making a major announcement regarding Russia, expressing his disappointment with the Vladimir Putin-led nation. These developments mark a sharp pivot in trade and geopolitical tone under his revived leadership ambitions.
- US jobless claims at 227,000 in July 5 week vs est of 235K
- US continuing claims at 1.965 Mn in June 28 week vs est of 1.965 Mn
Stocks to watch
- Glenmark Pharma: Its arm IGI Therapeutics SA signed an exclusive global licensing deal with AbbVie for cancer and autoimmune drug ISB 2001, currently in Phase I trials. IGI will receive $700 million upfront and is eligible for up to $1.225 billion in milestone payments. AbbVie gains exclusive rights across North America, Europe, Japan, and Greater China.
- Zee Entertainment: Shareholders rejected the ₹2,237 crore warrant issuance proposal to promoters, with only 59.5% votes in favor, falling short of the required threshold as 40.5% voted against the resolution.
- Senores Pharma: The company acquired 2.97% stake in Havix Group Inc.
- PC Jeweller: The company raised Rs 500 crore by preferential allotment of shares & warrants on a private placement basis.
- Ircon International: SA Yadav initiates a claim of Rs 72.9 crore against the company in the Arbitral Tribunal.
- Popular Vehicles: Arm received a letter of intent for setting up Ather facilities in Chennai.
- Mphasis: Mphasis acquired a 26% stake in Aokah, a Delaware-based Corp. in the US for $4 million.
- Consolidated Construction: The company received Rs 200 crore order for the construction of buildings and factories.
- Aegis Logistics: The company agrees to transfer the Pipavav LPG cryogenic terminal to Aegis Vopak Terminals for Rs 428 crore.
- Tourism Finance Corp: The board approved splitting one existing share into five.
- M&M Financial Services: The company approved the issuance of NCDs worth up to Rs 100 crore on a private placement basis.
- Bank of Baroda: The bank reduced its overnight MCLR rate by 5 basis points effective July 12.
- Krystal Integrated: The company received Rs 20.3 crore facility management contract for the New Terminal at Patna Airport.
- JSW Infra: The creditors approved the company’s resolution plan for NCR rail Infrastructure.
- Tata Steel: The company acquired 124.6 crore shares aggregating to Rs 1,074 crore in foreign arm T steel holdings Pte.
- Adani Green Energy: The company’s Q1 FY26 operational capacity rose 45% year-on-year to 15,816 MW, driven by a greenfield addition of 4,882 MW.
- Its energy sales for the quarter grew 42% YoY to 10,479 million units, supported by the robust capacity expansion.
Written by Manideep Appana
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
